Motivation for treatment in patients with chronic cardiorenal syndrome


Cite item

Full Text

Abstract

Aim. To study treatment motivation in patients with chronic heart failure (CHF) and in those with CHF concurrent with chronic kidney disease (CKD). Subjects and methods. A total of 203 patients (130 men and 73 women; mean age, 61.8±9.6 years) with CHF diagnosed and assessed in accordance with the National Guidelines of the All-Russian Research Society of Cardiology and the Heart Failure Society for the diagnosis and treatment of CHF (third edition, 2009) were examined. CKD was diagnosed according to the 2012 National Guidelines of the Research Nephrology Society of Russia. A group of patients with chronic cardiorenal syndrome (CRS) included those with CHF and CKD with a glomerular filtration rate (GFR) of <60 ml/min/1.73 m2. The clinical course of CHF, personality profile, and motivation for non-drug and drug treatments were assessed in patients with chronic CRS. Results. CFR was 67.7±17.2 ml/min/1.73 m2; chronic CRS was observed in 89 (44%) patients. Psychological functioning assessment showed that the patients with chronic CRS as compared with those with CHF without CKD had high anxiety and maladaptive disease attitudes. CHF treatment motivation (compliance with lifestyle modification and medication) was proved inadequate and detected only in 31 (15.3%) patients with CHF regardless of the presence of CKD. The specific features of psychological functioning, which affected treatment motivation, were seen in patients with chronic CRS: those who were lowly motivated had a euphoric attitude towards their disease (p=0.03); those who were satisfactorily motivated showed an emotive accentuation of character (p=0.002). Conclusion. The presence of CKD aggravates the clinical course of CHF and negatively affects the psychological functioning of patients with CHF. The patients with chronic CRS are characterized by a low level of motivation for both drug and non-drug treatments, which should be taken into account when managing this cohort of patients.

References

  1. Cvengros J, Christensen A, Lawton W. The role of perceived control and preference for control in adherence to chronic medical regimen. Ann Behavioral Med. 2004;27(3):155-161.
  2. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
  3. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med. 2012;10(2):142-151.
  4. Ronco C, Haapio C, House AA. Anavekar N, Bellomo R. Саrdiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539.
  5. Мухин Н.А., Фомин В.В., Моисеев С.В., Швецов М.Ю., Кутырина И.М. Кардиренальный синдром при ишемической болезни почек (атеросклеротической реноваскулярной гипертонии). Терапевтический архив. 2008;8:30-38.
  6. Шутов А.М., Серов В.А. Кардиоренальный и ренокардиальный синдромы. Нефрология. 2009;13(4):59-63.
  7. Мухин Н.А. Концепция персонифицированной медицины и клиническая нефрология. Клиническая нефрология. 2013;1:9-13.
  8. Серов В.А., Шутов А.М., Мензоров М.В., Макеева Е.Р., Серова Д.В. Эпидемиология хронической болезни почек у больных с хронической сердечной недостаточностью. Нефрология. 2010;14(1):50-55.
  9. Lee CS, Chien CV, Bidwell JT, Gelow JM, Denfeld QE, Masterson Creber R, Buck HG, Mudd JO. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Dis. 2014;14:73.
  10. Burnier M, Pruijm M, Wuerzner G, Santschi V. Drug adherence in chronic kidney diseases and dialysis. Nephrol Dial Transplant. 2015;30(1):39-44.
  11. Stromberg A. Patient-related factors of complians in heart failure: some new insights an old problem. Eur Heart J. 2006;27:379-381.
  12. Шилов Е.М., Добронравов Е.А., Каюков И.Г., Бобкова И.Н., Швецов Ю.М., Цыгин, А.Н., Шутов А.М. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология. 2012;4:3-43.
  13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383
  14. Леонова М.В., Мясоедова Н.В. Практические аспекты лечения АГ: эффективность и комплаентность. Российский кардиологический журнал. 2003;2:17-21.
  15. Альберт М.А., Биктимиров Т.З., Шутов. А.М. Приверженность к лечению и личностные особенности больных с хронической сердечной недостаточностью. Ученые записки Ульяновского государственного университета. 2008;1(13):6-9.
  16. Aronow WS, Ahn C, Mercando AD, Epstein S. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Card. 2000;86:1142-1143.
  17. Chamberlain AM, Sauver JL, Gerber Y, Manemann SM, Boyd CM, Dunlay SM, Rocca WA, Finney Rutten LJ, Jiang R, Weston SA, Roger VL. Multimorbidity in heart failure: a community perspective. Am J Med. 2015;128(1):38-45.
  18. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430-439.
  19. Birmelé B, Le Gall A, Sautenet B, Aguerre C, Camus V. Clinical, sociodemographic, and psychological correlates of health-related quality of life in chronic hemodialysis patients. Psychosomatics. 2012;53:30-37.
  20. Feroze U, Martin D, Kalantar-Zadeh K, Kim JC, Reina-Patton A, Kopple JD. Anxiety and depression in maintenance dialysis patients: preliminary data of a cross-sectional study and brief literature review. J Ren Nutr. 2012;22:207-210.
  21. Моисеев B.C., Мухин Н.А, Смирнов А.В. и др. Национальные рекомендации. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Клиническая нефрология. 2014;2:4-29.
  22. Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride M., Mehra MR, O’Connor CM, Reynolds D, Walsh MN. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010;105(8):1140-1146.
  23. García-Llana H, Remor E, Selgas R. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease udergoingdialysis. Psicothema. 2013;25(1):79-86.
  24. Clark S, Farrington K, Chilcot J. Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. SeminDial. 2014;27(1):42-49.
  25. Белялов Ф.И. Лечение внутренних болезней в условиях коморбидности: монография. 8-е изд. Иркутск: РИО ИГИУВа; 2012.
  26. Cox L, Kloseck M, Crilly R. Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. CanadianFamily Physician. 2011;57(17):263-269.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies